Jasper Therapeutics Ownership 2024 | Who Owns Jasper Therapeutics Now?
Institutional Ownership
68.35%
Insider Ownership
4.96%
Retail Ownership
26.69%
Institutional Holders
39.00
Jasper Therapeutics Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| COWEN AND COMPANY, LLC | - | - | - | -200,000 | -100.00% | - | Mar 31, 2024 |
| BANK OF AMERICA CORP /DE/ | - | - | - | -3,180,059 | -100.00% | - | Mar 31, 2024 |
| WELLS FARGO & COMPANY/MN | - | - | - | -609 | -100.00% | - | Mar 31, 2024 |
| NORTHERN TRUST CORP | - | - | - | -154,909 | -100.00% | - | Mar 31, 2024 |
| STATE STREET CORP | - | - | - | -229,994 | -100.00% | - | Mar 31, 2024 |
| VANGUARD GROUP INC | - | - | - | -4,092,958 | -100.00% | - | Mar 31, 2024 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | - | - | - | -36,899 | -100.00% | - | Mar 31, 2024 |
| MORGAN STANLEY | - | - | - | -1,699,550 | -100.00% | - | Mar 31, 2024 |
| BANK OF MONTREAL /CAN/ | - | - | - | -348,300 | -100.00% | - | Mar 31, 2024 |
| GROUP ONE TRADING, L.P. | - | - | - | -1 | -100.00% | - | Mar 31, 2024 |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | - | - | - | -3,540,000 | -100.00% | - | Mar 31, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | - | - | - | -514,324 | -100.00% | - | Mar 31, 2024 |
| GRIES FINANCIAL LLC | - | - | - | -23,845 | -100.00% | - | Mar 31, 2024 |
| TWO SIGMA INVESTMENTS, LP | - | - | - | -54,168 | -100.00% | - | Mar 31, 2024 |
| LAZARD ASSET MANAGEMENT LLC | - | - | - | -11,500 | -100.00% | - | Mar 31, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | - | - | - | -904,477 | -100.00% | - | Mar 31, 2024 |
| MILLENNIUM MANAGEMENT LLC | - | - | - | -129,883 | -100.00% | - | Mar 31, 2024 |
| BLACKROCK INC. | - | - | - | -1,323,972 | -100.00% | - | Mar 31, 2024 |
| MARINER, LLC | - | - | - | -590,510 | -100.00% | - | Mar 31, 2024 |
| BANK OF NEW YORK MELLON CORP | - | - | - | -43,593 | -100.00% | - | Mar 31, 2024 |
Jasper Therapeutics's largest institutional shareholder is COWEN AND COMPANY, LLC, holding 0.00% of the company's total share outstanding, currently valued at -. The top 10 institutional shareholders own together 0.00% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| COWEN AND COMPANY, LLC | - | - | - | -200,000 | -100.00% | - | Mar 31, 2024 |
| BANK OF AMERICA CORP /DE/ | - | - | - | -3,180,059 | -100.00% | - | Mar 31, 2024 |
| WELLS FARGO & COMPANY/MN | - | - | - | -609 | -100.00% | - | Mar 31, 2024 |
| NORTHERN TRUST CORP | - | - | - | -154,909 | -100.00% | - | Mar 31, 2024 |
| STATE STREET CORP | - | - | - | -229,994 | -100.00% | - | Mar 31, 2024 |
| VANGUARD GROUP INC | - | - | - | -4,092,958 | -100.00% | - | Mar 31, 2024 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | - | - | - | -36,899 | -100.00% | - | Mar 31, 2024 |
| MORGAN STANLEY | - | - | - | -1,699,550 | -100.00% | - | Mar 31, 2024 |
| BANK OF MONTREAL /CAN/ | - | - | - | -348,300 | -100.00% | - | Mar 31, 2024 |
| GROUP ONE TRADING, L.P. | - | - | - | -1 | -100.00% | - | Mar 31, 2024 |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | - | - | - | -3,540,000 | -100.00% | - | Mar 31, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | - | - | - | -514,324 | -100.00% | - | Mar 31, 2024 |
| GRIES FINANCIAL LLC | - | - | - | -23,845 | -100.00% | - | Mar 31, 2024 |
| TWO SIGMA INVESTMENTS, LP | - | - | - | -54,168 | -100.00% | - | Mar 31, 2024 |
| LAZARD ASSET MANAGEMENT LLC | - | - | - | -11,500 | -100.00% | - | Mar 31, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | - | - | - | -904,477 | -100.00% | - | Mar 31, 2024 |
| MILLENNIUM MANAGEMENT LLC | - | - | - | -129,883 | -100.00% | - | Mar 31, 2024 |
| BLACKROCK INC. | - | - | - | -1,323,972 | -100.00% | - | Mar 31, 2024 |
| MARINER, LLC | - | - | - | -590,510 | -100.00% | - | Mar 31, 2024 |
| BANK OF NEW YORK MELLON CORP | - | - | - | -43,593 | -100.00% | - | Mar 31, 2024 |
The largest Jasper Therapeutics shareholder by % of total assets is COWEN AND COMPANY, LLC. The company owns 0.00 shares of Jasper Therapeutics (JSPR), representing 0.00% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| GROUP ONE TRADING, L.P. | - | - | - | -1 | -100.00% | - | Mar 31, 2024 |
| WELLS FARGO & COMPANY/MN | - | - | - | -609 | -100.00% | - | Mar 31, 2024 |
| TOWER RESEARCH CAPITAL LLC (TRC) | - | - | - | -11,144 | -100.00% | - | Mar 31, 2024 |
| JANE STREET GROUP, LLC | - | - | - | -11,209 | -100.00% | - | Mar 31, 2024 |
| LAZARD ASSET MANAGEMENT LLC | - | - | - | -11,500 | -100.00% | - | Mar 31, 2024 |
| GRIES FINANCIAL LLC | - | - | - | -23,845 | -100.00% | - | Mar 31, 2024 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | - | - | - | -36,899 | -100.00% | - | Mar 31, 2024 |
| BANK OF NEW YORK MELLON CORP | - | - | - | -43,593 | -100.00% | - | Mar 31, 2024 |
| TWO SIGMA INVESTMENTS, LP | - | - | - | -54,168 | -100.00% | - | Mar 31, 2024 |
| IEQ CAPITAL, LLC | - | - | - | -54,500 | -100.00% | - | Mar 31, 2024 |
| SUMMIT TRAIL ADVISORS, LLC | - | - | - | -65,000 | -100.00% | - | Mar 31, 2024 |
| MILLENNIUM MANAGEMENT LLC | - | - | - | -129,883 | -100.00% | - | Mar 31, 2024 |
| NORTHERN TRUST CORP | - | - | - | -154,909 | -100.00% | - | Mar 31, 2024 |
| CITADEL ADVISORS LLC | - | - | - | -191,155 | -100.00% | - | Mar 31, 2024 |
| COWEN AND COMPANY, LLC | - | - | - | -200,000 | -100.00% | - | Mar 31, 2024 |
| STATE STREET CORP | - | - | - | -229,994 | -100.00% | - | Mar 31, 2024 |
| MONACO ASSET MANAGEMENT SAM | - | - | - | -249,563 | -100.00% | - | Mar 31, 2024 |
| BANK OF MONTREAL /CAN/ | - | - | - | -348,300 | -100.00% | - | Mar 31, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | - | - | - | -514,324 | -100.00% | - | Mar 31, 2024 |
| MARINER, LLC | - | - | - | -590,510 | -100.00% | - | Mar 31, 2024 |
As of Mar 31 2024, Jasper Therapeutics's largest institutional buyer is GROUP ONE TRADING, L.P.. The company purchased -1.00 stocks of JSPR, valued at -.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| VELAN CAPITAL INVESTMENT MANAGEMENT LP | - | - | - | -11,219,036 | -100.00% | - | Mar 31, 2024 |
| SOLEUS CAPITAL MANAGEMENT, L.P. | - | - | - | -9,870,980 | -100.00% | - | Mar 31, 2024 |
| CARLYLE GROUP INC. | - | - | - | -8,761,891 | -100.00% | - | Mar 31, 2024 |
| QIMING U.S. VENTURES MANAGEMENT, LLC | - | - | - | -8,519,648 | -100.00% | - | Mar 31, 2024 |
| OCTAGON CAPITAL ADVISORS LP | - | - | - | -4,468,114 | -100.00% | - | Mar 31, 2024 |
| VANGUARD GROUP INC | - | - | - | -4,092,958 | -100.00% | - | Mar 31, 2024 |
| OPALEYE MANAGEMENT INC. | - | - | - | -3,985,340 | -100.00% | - | Mar 31, 2024 |
| ALLY BRIDGE GROUP (NY) LLC | - | - | - | -3,659,255 | -100.00% | - | Mar 31, 2024 |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | - | - | - | -3,540,000 | -100.00% | - | Mar 31, 2024 |
| BANK OF AMERICA CORP /DE/ | - | - | - | -3,180,059 | -100.00% | - | Mar 31, 2024 |
| NANTAHALA CAPITAL MANAGEMENT, LLC | - | - | - | -2,228,265 | -100.00% | - | Mar 31, 2024 |
| WOODLINE PARTNERS LP | - | - | - | -1,732,993 | -100.00% | - | Mar 31, 2024 |
| MORGAN STANLEY | - | - | - | -1,699,550 | -100.00% | - | Mar 31, 2024 |
| SATURN V CAPITAL MANAGEMENT LLC | - | - | - | -1,386,215 | -100.00% | - | Mar 31, 2024 |
| BLACKROCK INC. | - | - | - | -1,323,972 | -100.00% | - | Mar 31, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | - | - | - | -904,477 | -100.00% | - | Mar 31, 2024 |
| LANDSCAPE CAPITAL MANAGEMENT, L.L.C. | - | - | - | -789,331 | -100.00% | - | Mar 31, 2024 |
| SPHERA FUNDS MANAGEMENT LTD. | - | - | - | -713,063 | -100.00% | - | Mar 31, 2024 |
| MARINER, LLC | - | - | - | -590,510 | -100.00% | - | Mar 31, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | - | - | - | -514,324 | -100.00% | - | Mar 31, 2024 |
As of Mar 31 2024, Jasper Therapeutics's biggest institutional seller is VELAN CAPITAL INVESTMENT MANAGEMENT LP. The company sold -11.22M shares of JSPR, valued at -.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| VELAN CAPITAL INVESTMENT MANAGEMENT LP | - | - | - | -11,219,036 | -100.00% | - | Mar 31, 2024 |
| SOLEUS CAPITAL MANAGEMENT, L.P. | - | - | - | -9,870,980 | -100.00% | - | Mar 31, 2024 |
| CARLYLE GROUP INC. | - | - | - | -8,761,891 | -100.00% | - | Mar 31, 2024 |
| QIMING U.S. VENTURES MANAGEMENT, LLC | - | - | - | -8,519,648 | -100.00% | - | Mar 31, 2024 |
| OCTAGON CAPITAL ADVISORS LP | - | - | - | -4,468,114 | -100.00% | - | Mar 31, 2024 |
| VANGUARD GROUP INC | - | - | - | -4,092,958 | -100.00% | - | Mar 31, 2024 |
| OPALEYE MANAGEMENT INC. | - | - | - | -3,985,340 | -100.00% | - | Mar 31, 2024 |
| ALLY BRIDGE GROUP (NY) LLC | - | - | - | -3,659,255 | -100.00% | - | Mar 31, 2024 |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | - | - | - | -3,540,000 | -100.00% | - | Mar 31, 2024 |
| BANK OF AMERICA CORP /DE/ | - | - | - | -3,180,059 | -100.00% | - | Mar 31, 2024 |
| NANTAHALA CAPITAL MANAGEMENT, LLC | - | - | - | -2,228,265 | -100.00% | - | Mar 31, 2024 |
| WOODLINE PARTNERS LP | - | - | - | -1,732,993 | -100.00% | - | Mar 31, 2024 |
| MORGAN STANLEY | - | - | - | -1,699,550 | -100.00% | - | Mar 31, 2024 |
| SATURN V CAPITAL MANAGEMENT LLC | - | - | - | -1,386,215 | -100.00% | - | Mar 31, 2024 |
| BLACKROCK INC. | - | - | - | -1,323,972 | -100.00% | - | Mar 31, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | - | - | - | -904,477 | -100.00% | - | Mar 31, 2024 |
| LANDSCAPE CAPITAL MANAGEMENT, L.L.C. | - | - | - | -789,331 | -100.00% | - | Mar 31, 2024 |
| SPHERA FUNDS MANAGEMENT LTD. | - | - | - | -713,063 | -100.00% | - | Mar 31, 2024 |
| MARINER, LLC | - | - | - | -590,510 | -100.00% | - | Mar 31, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | - | - | - | -514,324 | -100.00% | - | Mar 31, 2024 |
| BANK OF MONTREAL /CAN/ | - | - | - | -348,300 | -100.00% | - | Mar 31, 2024 |
| MONACO ASSET MANAGEMENT SAM | - | - | - | -249,563 | -100.00% | - | Mar 31, 2024 |
| STATE STREET CORP | - | - | - | -229,994 | -100.00% | - | Mar 31, 2024 |
| COWEN AND COMPANY, LLC | - | - | - | -200,000 | -100.00% | - | Mar 31, 2024 |
| CITADEL ADVISORS LLC | - | - | - | -191,155 | -100.00% | - | Mar 31, 2024 |
| NORTHERN TRUST CORP | - | - | - | -154,909 | -100.00% | - | Mar 31, 2024 |
| MILLENNIUM MANAGEMENT LLC | - | - | - | -129,883 | -100.00% | - | Mar 31, 2024 |
| SUMMIT TRAIL ADVISORS, LLC | - | - | - | -65,000 | -100.00% | - | Mar 31, 2024 |
| IEQ CAPITAL, LLC | - | - | - | -54,500 | -100.00% | - | Mar 31, 2024 |
| TWO SIGMA INVESTMENTS, LP | - | - | - | -54,168 | -100.00% | - | Mar 31, 2024 |
| BANK OF NEW YORK MELLON CORP | - | - | - | -43,593 | -100.00% | - | Mar 31, 2024 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | - | - | - | -36,899 | -100.00% | - | Mar 31, 2024 |
| GRIES FINANCIAL LLC | - | - | - | -23,845 | -100.00% | - | Mar 31, 2024 |
| LAZARD ASSET MANAGEMENT LLC | - | - | - | -11,500 | -100.00% | - | Mar 31, 2024 |
| JANE STREET GROUP, LLC | - | - | - | -11,209 | -100.00% | - | Mar 31, 2024 |
| TOWER RESEARCH CAPITAL LLC (TRC) | - | - | - | -11,144 | -100.00% | - | Mar 31, 2024 |
| WELLS FARGO & COMPANY/MN | - | - | - | -609 | -100.00% | - | Mar 31, 2024 |
| GROUP ONE TRADING, L.P. | - | - | - | -1 | -100.00% | - | Mar 31, 2024 |
Jasper Therapeutics's largest sold out institutional shareholder by shares sold is VELAN CAPITAL INVESTMENT MANAGEMENT LP, sold -11.22M shares, valued at -, as of undefined.
Jasper Therapeutics Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| VANGUARD VALLEY FORGE FUNDS | 0.12% | 57,934 | - | - | Dec 31, 2023 |
| VANGUARD INDEX FUNDS | 0.01% | 5,093,695 | 1,460,011 | 40.18% | Dec 31, 2023 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 827,978 | - | - | Feb 29, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 74,930 | - | - | Dec 31, 2023 |
| SCHWAB CAPITAL TRUST | 0.00% | 36,899 | - | - | Feb 29, 2024 |
| iSHARES TRUST | 0.00% | 177,380 | - | - | Feb 29, 2024 |
| EQ ADVISORS TRUST | 0.00% | 11,532 | -3,217 | -21.81% | Dec 31, 2023 |
| AMERICAN CENTURY ETF TRUST | 0.00% | 100 | 100 | - | Feb 29, 2024 |
Jasper Therapeutics's largest mutual fund holder by % of total assets is "VANGUARD VALLEY FORGE FUNDS", owning 57.93K shares, compromising 0.12% of its total assets.
Jasper Therapeutics Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 31 Dec, 23 | 39 | -7.14% |
| 30 Sep, 23 | 42 | -12.50% |
| 30 Jun, 23 | 48 | - |
| 31 Mar, 23 | 48 | 118.18% |
| 31 Dec, 22 | 22 | 15.79% |
| 30 Sep, 22 | 19 | -9.52% |
| 30 Jun, 22 | 21 | -8.70% |
| 31 Mar, 22 | 23 | -14.81% |
| 31 Dec, 21 | 27 | 200.00% |
| 30 Sep, 21 | 9 | - |
As of 31 Dec 23, 39 institutions are holding Jasper Therapeutics's shares, representing a decrease of -7.14% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 31 Dec, 23 | 74,996,253 | -18.08% |
| 30 Sep, 23 | 91,546,602 | 3.92% |
| 30 Jun, 23 | 88,090,697 | -5.96% |
| 31 Mar, 23 | 93,678,433 | 363.47% |
| 31 Dec, 22 | 20,212,224 | -0.61% |
| 30 Sep, 22 | 20,335,402 | 2.22% |
| 30 Jun, 22 | 19,894,189 | -0.80% |
| 31 Mar, 22 | 20,053,919 | -4.12% |
| 31 Dec, 21 | 20,914,592 | 103.09% |
| 30 Sep, 21 | 10,298,176 | - |
Jasper Therapeutics (JSPR) has 75.00M shares outstanding as of 31 Dec 23, down -18.08% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 31 Dec, 23 | 68.35% | 0.97% |
| 30 Sep, 23 | 83.82% | 0.84% |
| 30 Jun, 23 | 99.92% | 0.88% |
| 31 Mar, 23 | 106.26% | 20.22% |
| 31 Dec, 22 | 22.93% | 4.31% |
| 30 Sep, 22 | 23.07% | 4.53% |
| 30 Jun, 22 | 22.57% | 4.36% |
| 31 Mar, 22 | 22.75% | 4.04% |
| 31 Dec, 21 | 23.72% | 17.39% |
| 30 Sep, 21 | 11.68% | - |
As of 31 Dec 23, Jasper Therapeutics is held by 68.35% institutional shareholders, representing a 0.97% growth compared to 30 Sep 23.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 31 Dec, 23 | 17 | - |
| 30 Sep, 23 | 17 | -5.56% |
| 30 Jun, 23 | 18 | -59.09% |
| 31 Mar, 23 | 44 | 340.00% |
| 31 Dec, 22 | 10 | 11.11% |
| 30 Sep, 22 | 9 | -25.00% |
| 30 Jun, 22 | 12 | 50.00% |
| 31 Mar, 22 | 8 | -61.90% |
| 31 Dec, 21 | 21 | 133.33% |
| 30 Sep, 21 | 9 | - |
17 institutional shareholders have increased their position in JSPR stock as of 31 Dec 23 compared to 17 in the previous quarter (a 0.00% increase).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 31 Dec, 23 | 9 | 28.57% |
| 30 Sep, 23 | 7 | -30.00% |
| 30 Jun, 23 | 10 | 900.00% |
| 31 Mar, 23 | 1 | -80.00% |
| 31 Dec, 22 | 5 | 150.00% |
| 30 Sep, 22 | 2 | -33.33% |
| 30 Jun, 22 | 3 | -57.14% |
| 31 Mar, 22 | 7 | 133.33% |
| 31 Dec, 21 | 3 | - |
| 30 Sep, 21 | - | - |
9 institutional shareholders have reduced their position in JSPR stock as of 31 Dec 23 compared to 7 in the previous quarter (a 28.57% increase).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 31 Dec, 23 | 39 | -7.14% | 74,996,253 | -18.08% | 68.35% | 0.97% | 17 | - | 9 | 28.57% |
| 30 Sep, 23 | 42 | -12.50% | 91,546,602 | 3.92% | 83.82% | 0.84% | 17 | -5.56% | 7 | -30.00% |
| 30 Jun, 23 | 48 | - | 88,090,697 | -5.96% | 99.92% | 0.88% | 18 | -59.09% | 10 | 900.00% |
| 31 Mar, 23 | 48 | 118.18% | 93,678,433 | 363.47% | 106.26% | 20.22% | 44 | 340.00% | 1 | -80.00% |
| 31 Dec, 22 | 22 | 15.79% | 20,212,224 | -0.61% | 22.93% | 4.31% | 10 | 11.11% | 5 | 150.00% |
| 30 Sep, 22 | 19 | -9.52% | 20,335,402 | 2.22% | 23.07% | 4.53% | 9 | -25.00% | 2 | -33.33% |
| 30 Jun, 22 | 21 | -8.70% | 19,894,189 | -0.80% | 22.57% | 4.36% | 12 | 50.00% | 3 | -57.14% |
| 31 Mar, 22 | 23 | -14.81% | 20,053,919 | -4.12% | 22.75% | 4.04% | 8 | -61.90% | 7 | 133.33% |
| 31 Dec, 21 | 27 | 200.00% | 20,914,592 | 103.09% | 23.72% | 17.39% | 21 | 133.33% | 3 | - |
| 30 Sep, 21 | 9 | - | 10,298,176 | - | 11.68% | - | 9 | - | - | - |
Jasper Therapeutics Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
Insider Sells
All Insider Owners Trades
The last insider sell of Jasper Therapeutics's stock was made by Mahal Jeetinder Singh on Mar 12 2024, selling 900 shares at $26.44 per share (valued at $23.79K). The last insider buy of JSPR was made by Carlyle Group Inc. on Feb 12 2024, buying 190,000 shares at $12.95 per share (worth $2.46M).
Jasper Therapeutics Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q1 2024 | 8 | 1 | 800.00% |
| Q4 2023 | 6 | 3 | 200.00% |
| Q3 2023 | 1 | - | - |
| Q2 2023 | 11 | 6 | 183.33% |
| Q1 2023 | 6 | 2 | 300.00% |
| Q4 2022 | 8 | - | - |
| Q3 2022 | - | - | - |
| Q2 2022 | 1 | 2 | 50.00% |
| Q1 2022 | 18 | - | - |
| Q3 2021 | 12 | 7 | 171.43% |
| Q2 2021 | - | 3 | - |
| Q1 2021 | - | 7 | - |
| Q4 2020 | - | 8 | - |
| Q3 2020 | - | 9 | - |
| Q1 2020 | - | 4 | - |
| Q4 2019 | - | 1 | - |
8 total buy trades, and 1 total sell trades (buy/sell ratio of 8.00%) were made by Jasper Therapeutics's insiders, as of Q1 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q1 2024 | 2 | 1 | 200.00% |
| Q4 2023 | 5 | 1 | 500.00% |
| Q3 2023 | - | - | - |
| Q2 2023 | - | 4 | - |
| Q1 2023 | 2 | 1 | 200.00% |
| Q4 2022 | - | - | - |
| Q3 2022 | - | - | - |
| Q2 2022 | - | 2 | - |
| Q1 2022 | - | - | - |
| Q3 2021 | - | - | - |
| Q2 2021 | - | 3 | - |
| Q1 2021 | - | 6 | - |
| Q4 2020 | - | 8 | - |
| Q3 2020 | - | 9 | - |
| Q1 2020 | - | - | - |
| Q4 2019 | - | - | - |
As of Q1 2024, Insider owners conducted 2 open market buy trades and 1 open market sell trades of Jasper Therapeutics's stocks.
Jasper Therapeutics Peer Ownership
| Ticker | Company |
|---|---|
| DSGN | Design Therapeutics, Inc. |
| ABOS | Acumen Pharmaceuticals, Inc. |
| GRTX | Galera Therapeutics, Inc. |
| ORIC | ORIC Pharmaceuticals, Inc. |
| ELYM | Eliem Therapeutics, Inc. |
| INBX | Inhibrx, Inc. |
| EQ | Equillium, Inc. |
| ELDN | Eledon Pharmaceuticals, Inc. |
| INZY | Inozyme Pharma, Inc. |
| EWTX | Edgewise Therapeutics, Inc. |
| LIAN | LianBio |
| IKNA | Ikena Oncology, Inc. |
| HOOK | HOOKIPA Pharma Inc. |
| XLO | Xilio Therapeutics, Inc. |
| EPIX | ESSA Pharma Inc. |
| LYRA | Lyra Therapeutics, Inc. |
JSPR Ownership FAQ
Who Owns Jasper Therapeutics?
Jasper Therapeutics is owned by institutional shareholders (68.35%), insiders (4.96%), and public (26.69%). The largest institutional shareholder of Jasper Therapeutics is COWEN AND COMPANY, LLC (0% of total shares) and the top mutual fund owner is VANGUARD VALLEY FORGE FUNDS (0.12% of total shares).
Who are the major institutional shareholders of Jasper Therapeutics?
Jasper Therapeutics's major institutional shareholders are COWEN AND COMPANY, LLC, BANK OF AMERICA CORP /DE/, WELLS FARGO & COMPANY/MN, NORTHERN TRUST CORP, and STATE STREET CORP. The top five shareholders own together 0% of the company's share outstanding.
How many Jasper Therapeutics shareholders are there?
As of Dec 2023, there are 39 institutional shareholders of Jasper Therapeutics.
What percentage of Jasper Therapeutics is owned by COWEN AND COMPANY, LLC?
COWEN AND COMPANY, LLC owns 0 shares of Jasper Therapeutics, representing 0% of the company's total shares outstanding, valued at $0 (as of Mar 2024).
What percentage of Jasper Therapeutics is owned by BANK OF AMERICA CORP /DE/?
As of Mar 2024, BANK OF AMERICA CORP /DE/ holds 0 shares of Jasper Therapeutics (JSPR), compromising 0% of the company, valued at $0.
What percentage of Jasper Therapeutics is owned by WELLS FARGO & COMPANY/MN?
WELLS FARGO & COMPANY/MN is the third largest holder of Jasper Therapeutics. The company owns 0 of the company's shares outstanding (worth $0).